Cargando…

Chinese herbal medicine for resistant hypertension: a systematic review

OBJECTIVES: This study aimed to summarise the current evidence from randomised control trials (RCTs) concerning treatment of patients with resistant hypertension with Chinese herbal medicine (CHM). DESIGN: Seven databases, including the Cochrane Library, PubMed, EMBASE, CNKI, VIP, CBM and Wanfang, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Xingjiang, Li, Xiaoke, Zhang, Yuqing, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316421/
https://www.ncbi.nlm.nih.gov/pubmed/25636788
http://dx.doi.org/10.1136/bmjopen-2014-005355
_version_ 1782355562486300672
author Xiong, Xingjiang
Li, Xiaoke
Zhang, Yuqing
Wang, Jie
author_facet Xiong, Xingjiang
Li, Xiaoke
Zhang, Yuqing
Wang, Jie
author_sort Xiong, Xingjiang
collection PubMed
description OBJECTIVES: This study aimed to summarise the current evidence from randomised control trials (RCTs) concerning treatment of patients with resistant hypertension with Chinese herbal medicine (CHM). DESIGN: Seven databases, including the Cochrane Library, PubMed, EMBASE, CNKI, VIP, CBM and Wanfang, were systematically searched from their inception to March 2014 for RCTs investigating treatment of resistant hypertension in which CHM was used either as a monotherapy or in combination with conventional medicine versus placebo, no intervention or conventional medicine. RESULTS: Five trials containing 446 hypertensive patients were identified. The methodological quality of most trials was evaluated as generally low. All included trials compared CHM plus antihypertensive drugs with antihypertensive drugs alone for resistant hypertension. Formulations of CHM included tablet, decoction and injection. It was found that, compared with antihypertensive drugs alone, CHM (tablet) plus antihypertensive drugs resulted in clinically, but not statistically, significant reductions in systolic blood pressure (SBP; weighted mean difference (WMD)=−10.32 mm Hg; 95% CI −21.10 to 0.46; p=0.06) and diastolic blood pressure (DBP; WMD=−3.30 mm Hg; 95% CI −7.66 to 1.06; p=0.14). CHM (decoction) plus antihypertensive drugs also produced a clinically meaningful, but not statistically significant, reduction in SBP (WMD=−12.56 mm Hg; 95% CI −26.83 to 1.71; p=0.08), and did significantly decrease DBP (WMD=−7.89 mm Hg; 95% CI −11.74 to −4.04; p<0.0001). There were no significant differences in SBP (WMD=−3.50 mm Hg; 95% CI −8.95 to 1.95; p=0.21) and DBP (WMD=1.00 mm Hg; 95% CI −1.39 to 3.39; p=0.41) between CHM (injection) plus the antihypertensive drugs group and antihypertensive drugs alone. The safety of CHM remained uncertain. CONCLUSIONS: No definite conclusions about the effectiveness and safety of CHM for resistant hypertension could be drawn. More rigorously designed trials are warranted.
format Online
Article
Text
id pubmed-4316421
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43164212015-02-10 Chinese herbal medicine for resistant hypertension: a systematic review Xiong, Xingjiang Li, Xiaoke Zhang, Yuqing Wang, Jie BMJ Open Complementary Medicine OBJECTIVES: This study aimed to summarise the current evidence from randomised control trials (RCTs) concerning treatment of patients with resistant hypertension with Chinese herbal medicine (CHM). DESIGN: Seven databases, including the Cochrane Library, PubMed, EMBASE, CNKI, VIP, CBM and Wanfang, were systematically searched from their inception to March 2014 for RCTs investigating treatment of resistant hypertension in which CHM was used either as a monotherapy or in combination with conventional medicine versus placebo, no intervention or conventional medicine. RESULTS: Five trials containing 446 hypertensive patients were identified. The methodological quality of most trials was evaluated as generally low. All included trials compared CHM plus antihypertensive drugs with antihypertensive drugs alone for resistant hypertension. Formulations of CHM included tablet, decoction and injection. It was found that, compared with antihypertensive drugs alone, CHM (tablet) plus antihypertensive drugs resulted in clinically, but not statistically, significant reductions in systolic blood pressure (SBP; weighted mean difference (WMD)=−10.32 mm Hg; 95% CI −21.10 to 0.46; p=0.06) and diastolic blood pressure (DBP; WMD=−3.30 mm Hg; 95% CI −7.66 to 1.06; p=0.14). CHM (decoction) plus antihypertensive drugs also produced a clinically meaningful, but not statistically significant, reduction in SBP (WMD=−12.56 mm Hg; 95% CI −26.83 to 1.71; p=0.08), and did significantly decrease DBP (WMD=−7.89 mm Hg; 95% CI −11.74 to −4.04; p<0.0001). There were no significant differences in SBP (WMD=−3.50 mm Hg; 95% CI −8.95 to 1.95; p=0.21) and DBP (WMD=1.00 mm Hg; 95% CI −1.39 to 3.39; p=0.41) between CHM (injection) plus the antihypertensive drugs group and antihypertensive drugs alone. The safety of CHM remained uncertain. CONCLUSIONS: No definite conclusions about the effectiveness and safety of CHM for resistant hypertension could be drawn. More rigorously designed trials are warranted. BMJ Publishing Group 2015-01-30 /pmc/articles/PMC4316421/ /pubmed/25636788 http://dx.doi.org/10.1136/bmjopen-2014-005355 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Complementary Medicine
Xiong, Xingjiang
Li, Xiaoke
Zhang, Yuqing
Wang, Jie
Chinese herbal medicine for resistant hypertension: a systematic review
title Chinese herbal medicine for resistant hypertension: a systematic review
title_full Chinese herbal medicine for resistant hypertension: a systematic review
title_fullStr Chinese herbal medicine for resistant hypertension: a systematic review
title_full_unstemmed Chinese herbal medicine for resistant hypertension: a systematic review
title_short Chinese herbal medicine for resistant hypertension: a systematic review
title_sort chinese herbal medicine for resistant hypertension: a systematic review
topic Complementary Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316421/
https://www.ncbi.nlm.nih.gov/pubmed/25636788
http://dx.doi.org/10.1136/bmjopen-2014-005355
work_keys_str_mv AT xiongxingjiang chineseherbalmedicineforresistanthypertensionasystematicreview
AT lixiaoke chineseherbalmedicineforresistanthypertensionasystematicreview
AT zhangyuqing chineseherbalmedicineforresistanthypertensionasystematicreview
AT wangjie chineseherbalmedicineforresistanthypertensionasystematicreview